Impact of oral naloxegol vs subcutaneous methylnaltrexone in treatment of opioid-induced constipation in the hospital setting

The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety

(2020) Joseph V Pergolizzi Jr et al.   Drug Design Development and Therapy

Opioid-induced Constipation

(2020) Charles E. Argoff   CLINICAL JOURNAL OF PAIN

American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation

(2018) Seth D. Crockett et al.   GASTROENTEROLOGY

Methylnaltrexone Versus Naloxone for Opioid-Induced Constipation in the Medical Intensive Care Unit

(2016) Cristian Merchan et al.   ANNALS OF PHARMACOTHERAPY

Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities

(2015) Alfred D. Nelson et al.   Therapeutic Advances in Gastroenterology

Efficacy and Safety of Mu-Opioid Antagonists in the Treatment of Opioid-Induced Bowel Dysfunction: Systematic Review and Meta-analysis of Randomized Controlled Trials

(2007) Ewan McNicol et al.   PAIN MEDICINE